Nanocatalytic Regulation of Age-Related Diseases

Key Points

• The aim is to explore nanocatalytic approaches for regulating age-related diseases.
• Developed nanocatalytic interventions targeting key molecular pathways.
• Evaluated the efficacy of nanocatalysts in preclinical models.
• Utilized advanced biomarkers for assessing disease progression.
• Demonstrated significant reductions in markers of age-related diseases.
• Enhancements in cellular function and longevity observed in treated models.
• Provided evidence of improved efficacy compared to traditional approaches.